setmelanotide

setmelanotide
Trade Name
Orphan Indication Pro-opiomelanocortin Deficiency
USA Market Approval USA
USA Designation Date 2016-04-04 00:00:00
Sponsor Rhythm Pharmaceuticals, Inc.;855 Boylston Street, 11th Floor;Boston, Massachusetts, 02116